Core Viewpoint - Lida New Materials (603937.SH) reported its 2025 semi-annual results, highlighting an increase in institutional investor holdings and foreign investment interest [1] Institutional Holdings - As of August 27, 2025, four institutional investors disclosed holdings in Lida New Materials A-shares, totaling 2.6914 million shares, which represents 1.29% of the total share capital [1] - The institutional investors include China Construction Bank - Nuode Multi-Strategy Equity Fund, UBS AG, Goldman Sachs, and Barclays Bank PLC, with a total institutional holding ratio increasing by 1.29 percentage points compared to the previous quarter [1] Public Fund and Foreign Investment - One new public fund was disclosed in this period, namely Nuode Multi-Strategy Mixed A, compared to the previous quarter [1] - Three new foreign institutions disclosed their holdings, including UBS AG, Goldman Sachs, and Barclays Bank PLC, indicating a growing interest from foreign investors [1]

Group 1 - Zhejiang Lino (300838.SZ) released its semi-annual report for 2025 on August 28, 2025, indicating that as of August 27, 2025, five institutional investors disclosed holding shares, totaling 5.4705 million shares, which accounts for 3.96% of the total share capital [1] - The institutional investors include Ruian Nord Investment Partnership (Limited Partnership), Bank of China - Dachen Jingheng Mixed Securities Investment Fund, BARCLAYS BANK PLC, China Construction Bank - Nu'an Multi-Strategy Equity Fund, and Jianxin Flexible Allocation Mixed A, with a total institutional holding ratio increase of 1.01 percentage points compared to the previous quarter [1] - In the public fund sector, one public fund, Nu'an Multi-Strategy Mixed A, increased its holdings by 0.33% compared to the previous period, while a new public fund, Jianxin Flexible Allocation Mixed A, was disclosed in this period [1] Group 2 - In terms of foreign investment, one new foreign institution, BARCLAYS BANK PLC, disclosed its holdings in this period compared to the previous quarter [1]

Core Viewpoint - 威唐工业 (300707.SZ) reported its 2025 semi-annual results, highlighting an increase in institutional ownership and changes in public and foreign fund disclosures [1] Institutional Ownership - As of August 27, 2025, six institutional investors disclosed holdings in 威唐工业 A-shares, totaling 20.8999 million shares, which represents 11.81% of the total share capital [1] - The institutional ownership increased by 0.57 percentage points compared to the previous quarter [1] Public Fund Disclosures - One new public fund was disclosed this period, namely 诺安多策略混合A, while one public fund, 华安证券睿赢一年持有A, was not disclosed in this period [1] Foreign Investment - One new foreign institution, BARCLAYS BANK PLC, disclosed holdings this period, while 国泰君安金融控股有限公司-客户资金 was not disclosed in this period [1]

Core Insights - Xinguang Pharmaceutical (300519.SZ) released its semi-annual report for 2025, indicating a total of 29.12 million shares held by institutional investors, representing 18.20% of the company's total equity [1] Institutional Holdings - As of August 25, 2025, four institutional investors disclosed their holdings in Xinguang Pharmaceutical, with a combined ownership of 29.12 million shares, an increase of 0.75 percentage points from the previous quarter [1] - The institutional investors include Shengzhou Huanfeng Investment Co., Ltd., China Minsheng Bank Co., Ltd. - Jinyuan Shun'an Flexible Allocation Mixed Securities Investment Fund, BARCLAYS BANK PLC, and China Construction Bank Co., Ltd. - Nuoan Multi-Strategy Equity Fund [1] Public Fund Activity - One public fund, Jinyuan Shun'an Flexible Allocation Mixed Fund, increased its holdings compared to the previous period, while a new public fund, Nuoan Multi-Strategy Mixed A, was disclosed this quarter [1] - One public fund, Huatai-PineBridge CSI Traditional Chinese Medicine ETF, was not disclosed in this quarter compared to the previous one [1] Foreign Investment - One new foreign institutional investor, BARCLAYS BANK PLC, disclosed its holdings in Xinguang Pharmaceutical this quarter [1]

Group 1 - Huakang Clean (301235.SZ) released its semi-annual report for 2025 on July 30, 2025, with 10 institutional investors holding a total of 19.8267 million shares, accounting for 18.78% of the total share capital [1] - The top ten institutional investors include Sunshine Life Insurance Co., Ltd. - Dividend Insurance Product, Wuhan Kanghui Investment Management Center (Limited Partnership), and several others, with their combined holding ratio increasing by 0.56 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one fund, Nuon An Multi-Strategy Mixed A, increased its holdings by 0.20%, while two new public funds were disclosed, including Anxin Medical Health Stock A and China Merchants CSI 1000 Index Enhanced A [2] - In the insurance capital sector, Sunshine Life Insurance Co., Ltd. - Dividend Insurance Product reduced its holdings by 1.0% compared to the previous quarter [2] - Three new foreign institutional investors were disclosed, including BARCLAYS BANK PLC, J.P. Morgan Securities PLC - proprietary funds, and Goldman Sachs LLC [2]